发明名称 |
Pharmaceutical compositions with glycosaminoglycans and use thereof in the treatment of chronic ulcers |
摘要 |
The invention relates to a composition of glycosaminoglycans for the treatment of diabetic foot ulcer, it specifically relates to low molecular weight heparins (LMWHs) and very low molecular weight heparins (VLMWHs) in the treatment of chronic ulcers, particularly of diabetic foot ulcers, and more specifically in the manufacture of a medicinal product for the treatment of chronic ulcers, and particularly diabetic foot ulcers and pressure ulcers. |
申请公布号 |
US9211305(B2) |
申请公布日期 |
2015.12.15 |
申请号 |
US201314018840 |
申请日期 |
2013.09.05 |
申请人 |
Laboratories Farmaceuticos Roui, S.A. |
发明人 |
Encina Ivan Lopez-Belmonte;Canales Mayordomo Maria De Los Angeles;Cebadera Miranda Elena |
分类号 |
A61K31/70;A61K31/727;A61K9/00;A61K31/726;A61K47/26 |
主分类号 |
A61K31/70 |
代理机构 |
Innovar, L.L.C. |
代理人 |
Matos Rick;Innovar, L.L.C. |
主权项 |
1. A method of treating chronic foot ulcer in a diabetic subject having peripheral arterial occlusive disease comprising administering to the subject a daily dose of low molecular weight or very low molecular weight heparin having a plasma half-life ranging from 3 to 6.9 hours, wherein the average daily dose ranges from 5,000-10,000 IU. |
地址 |
Madrid ES |